SOX9 and Alzheimer disease: We counted the number of NFIA+ nuclei amongst SOX9+ astrocytic nuclei in each donor and found a significantly decreased proportion of SOX9+NFIA+ nuclei among the AD donors (41.1%) compared to normal controls (87.4%) (Fig. 6g).